Catarina Kiefe to Thrombolytic Therapy
This is a "connection" page, showing publications Catarina Kiefe has written about Thrombolytic Therapy.
Connection Strength
0.394
-
Canto JG, Kiefe CI. Door-to-needle time in myocardial infarction: is there an ideal benchmark? Am Heart J. 2005 Sep; 150(3):365-7.
Score: 0.227
-
Newsome BB, Warnock DG, Kiefe CI, Weissman NW, Houston TK, Centor RM, Person SD, McClellan WM, Allison JJ. Delay in time to receipt of thrombolytic medication among Medicare patients with kidney disease. Am J Kidney Dis. 2005 Oct; 46(4):595-602.
Score: 0.057
-
Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med. 2000 May 25; 342(21):1573-80.
Score: 0.039
-
Canto JG, Allison JJ, Kiefe CI, Fincher C, Farmer R, Sekar P, Person S, Weissman NW. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000 Apr 13; 342(15):1094-100.
Score: 0.039
-
Allison JJ, Kiefe CI, Centor RM, Box JB, Farmer RM. Racial differences in the medical treatment of elderly Medicare patients with acute myocardial infarction. J Gen Intern Med. 1996 Dec; 11(12):736-43.
Score: 0.031